Business Maverick After the Bell: NHI impasse could hobble second leg of business-government reform partnership By Ray Mahlaka
Maverick Citizen A dose of their own medicine — should SA force big drugmakers to let others make insulin pens too? By Christina Pitt
Business Maverick Aspen’s Novo Nordisk deal a ‘feather in our cap’ and an NCD battle boost - top executive By Georgina Crouth
South Africa Aspen’s Covid vaccine facility in Gqeberha switches to making insulin for Africa By Estelle Ellis
Business Maverick Latin American market lures SA companies looking to pad out their bottom line By Neesa Moodley
Business Maverick The Finance Ghost: Mixed fortunes at Sappi, Curro, Aspen, Telkom and Ellies By The Finance Ghost
Sci-Tech SA's pharmaceutical bargaining chip – if you test it here, it must be made available here at a reasonable price By Claire Waterhouse and Lebohang Kobola
Politics Exclusive: What Cyril Ramaphosa will say in his 2022 State of the Nation Address By Ferial Haffajee
South Africa ‘Don’t wait for Johnson & Johnson vaccine’ — acting director-general of health urges South Africa By Estelle Ellis